Friday, March 25, 2022

< + > Moderna Stock Plunges Despite 'Vaccine Day' Touting 31 New Shots And $21 Billion In Sales—Here's Why

One analyst blasted Moderna's flu vaccine results as a "non-starter" clinically, while others said investors are still too focused on Covid.

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

< + > Health Recovery Solutions Acquires Rimidi | Messagepoint Acquires Sefas

Check out today’s featured companies who have recently completed an M&A deal, and be sure to check out the full list of past healthcare ...